Fetal cells in transcervical samples at an early stage of gestation.
Several investigations are in progress with the aim of performing prenatal diagnosis of inherited disorders by noninvasive or minimally invasive techniques. The most important approaches are based on the detection of fetal nucleated cells in maternal blood, the analysis of fetal DNA present in maternal plasma, and the identification and isolation of fetal trophoblastic cellular elements shed into the uterine cavity and the endocervical canal. In this review, we discuss the methods that have been employed for the collection of the transcervical samples at an early stage of gestation and the techniques used for the identification of fetal cells. We also report the results of using endocervical cells for the detection of fetal chromosomal disorders by fluorescent in-situ hybridization and for performing prenatal diagnosis of fetal Rh(D) phenotypes. Recent investigations have also shown that--after the isolation of trophoblastic cells from maternal contaminants by micromanipulation--transcervical samples can be employed for the prenatal diagnosis of single gene defects, such as those causing thalassemia and sickle cell anemia. Although the present results are promising, further investigations are required to demonstrate the feasibility of performing accurate diagnosis of fetal diseases by this minimally invasive approach in all transcervical samples retrieved at an early stage of gestation.
Adinolfi
M
M
Department of Obstetrics and Gynaecology, University College of London, UK. matteo@galton.ucl.ac.uk
Sherlock
J
J
D002469:Cell Separation; D002584:Cervix Uteri; D004252:DNA Mutational Analysis; D005260:Female; D005333:Fetus / Q000166:cytology*; D030342:Genetic Diseases, Inborn / Q000175:diagnosis; D005865:Gestational Age; D006801:Humans; D008297:Male; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D013194:Staining and Labeling; D014327:Trophoblasts / Q000166:cytology